Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27119 | 0.83 | TSHR (0.45) | OR51E2TSHR | |
| SCHEMBL10342796 | 0.83 | OR51E2 (0.36) | OR51E2 | |
| SCHEMBL22367557 | 0.82 | TSHR (0.35) | TSHRGLO1 | |
| SCHEMBL145358 | 0.81 | ALDH1A1 (0.43) | OR51E2TSHR | |
| SCHEMBL93977 | 0.80 | OR51E2 (0.50) | OR51E2 | |
| SCHEMBL4734172 | 0.78 | — | — | |
| Propane SCHEMBL21814344 | 0.78 | OR51E2 (0.43) | OR51E2TSHR | |
| Alcohol SCHEMBL6238241 | 0.78 | OR51E2 (0.43) | OR51E2TSHR | |
| Water SCHEMBL22418485 | 0.78 | OR51E2 (0.55) | OR51E2 | |
| SCHEMBL4985589 | 0.78 | OR51E2 (0.48) | OR51E2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7417071-B2 | Antioxidant triacylglycerols and lipid compositions | ALBERTA RESEARCH COUNCIL INC. (CA) | 2008-08-26 | — | — | US | disclosed |
| US-7041840-B2 | Antioxidant triacylglycerols and lipid compositions | ALBERTA RESEARCH COUNCIL INC. (CA) | 2006-05-09 | — | — | US | disclosed |
| US-20050165101-A1 | ANTIOXIDANT TRIACYLGLYCEROLS AND LIPID COMPOSITIONS | ALBERTA INNOVATES - TECHNOLOGY FUTURES (CA) | 2005-07-28 | — | — | US | disclosed |
| US-20040122093-A1 | delivers essential or beneficial fatty acids in an optimal manner with respect to stability and biosorptivity | ALBERTA RESEARCH COUNCIL INC. (CA) | 2004-06-24 | — | — | US | disclosed |
| EP-1430782-A1 | Antioxidant triacylglycerols and lipid compositions | Alberta Research Council, Inc. (CA) | 2004-06-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050165101-A1 | ANTIOXIDANT TRIACYLGLYCEROLS AND LIPID COMPOSITIONS | LIPC, GPX4, GPX1 | OR51E2 4475/4885TSHR 3586/4885GLO1 117/4885 |
| US-20040122093-A1 | delivers essential or beneficial fatty acids in an optimal manner with respect to stability and biosorptivity | ELOVL1, LIPC, TTPA | OR51E2 1580/4885TSHR 2473/4885GLO1 288/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.